Drug interactions
Buprenorphine long-acting + Pancuronium
Severity: Moderate
Buprenorphine long-acting and Pancuronium: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Opioids such as buprenorphine cause sedation and respiratory depression, and in a patient receiving pancuronium this matters mainly during recovery from paralysis and in ventilation weaning. In practice pancuronium is used with controlled ventilation, so the risk is mostly of residual respiratory depression after extubation.
What this interaction means in plain words
Buprenorphine long-acting and Pancuronium can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Additive respiratory depression from opioid central effects and neuromuscular blockade from pancuronium.
What to do
Ensure controlled ventilation during paralysis and monitor respiratory function and sedation closely after neuromuscular blockade is reversed.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine long-acting and Pancuronium, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Pancuronium
Frequently asked questions
Can I take Buprenorphine long-acting with Pancuronium?
MediHelp rates the interaction as moderate. Buprenorphine long-acting and Pancuronium can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Opioids such as buprenorphine cause sedation and respiratory depression, and in a patient receiving pancuronium this matters mainly during recovery from paralysis and in ventilation weaning. In practice pancuronium is used with controlled ventilation, so the risk is mostly of residual respiratory depression after extubation.
How serious is the interaction between Buprenorphine long-acting and Pancuronium?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Ensure controlled ventilation during paralysis and monitor respiratory function and sedation closely after neuromuscular blockade is reversed.
What other medicines interact with Pancuronium?
MediHelp also lists interactions of Pancuronium with, for example, Amikacin, Bacitracin-neomycin-polymyxin, Capreomycin. The full list is on the Pancuronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
